A team from Saul Ewing has appeared on behalf of Samsung Bioepis, which faces a patent infringement complaint from Amgen over development of biologic drugs similar to two of the biopharmaceutical giant’s top-performing products.
William Baton, Sarah Sullivan and Alexander Callo appeared Tuesday in the U.S. District Court for the District of New Jersey in Camden.
